Aaron Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Aaron Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$537K	Sell	1,449 -168	-10%	-$59.3K	0.03%	420
2026 Q2	$581K	Buy	+1,617	New	+$494K	0.03%	382
2025 Q4	–	Sell	-1,049	Closed	-$275K	–	719
2025 Q3	$275K	Buy	+1,049	New	+$255K	0.02%	544
2022 Q2	–	Sell	-159	Closed	-$65.3K	–	852
2022 Q1	$65.3K	Buy	+159	New	+$62.2K	0.02%	368

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Aaron Wealth Advisors's WST Position: Q3 2026 in Review

Aaron Wealth Advisors reduced its West Pharmaceutical (WST) stake by 10% in Q3 2026, selling an estimated $59.3K and leaving 1,449 shares worth $537K. The position accounts for 0.03% of the portfolio, ranked #420.

Aaron Wealth Advisors first reported a position in WST in Q1 2022 and has held it in 4 quarters since. The position peaked at $581K in Q2 2026. 189 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Aaron Wealth Advisors held 1,449 shares of West Pharmaceutical worth $537K as of Q3 2026.
Aaron Wealth Advisors sold 168 West Pharmaceutical shares in Q3 2026, an estimated $59.3K.
West Pharmaceutical made up 0.03% of Aaron Wealth Advisors's portfolio in Q3 2026, its #420 holding.
Aaron Wealth Advisors first reported a position in West Pharmaceutical in Q1 2022 and has held it in 4 quarters since.
Aaron Wealth Advisors's West Pharmaceutical position peaked at $581K in Q2 2026.
189 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Aaron Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.